QMSMEDI QMS Medical Allied Services Q1 FY26 results (Apr–Jun 2025) and concall
QMS Medical Allied Services reported a strong Q1 FY26 with record revenue of ₹46.5 crores, a 53% YoY increase, driven by robust performance in both products and services. EBITDA and PAT also saw significant growth. The company's Q-Devices segment achieved ₹10 crores in revenue in Q1, exceeding its entire FY25 performance, and the services business, including the acquired Saarathi, showed substantial growth. Management acknowledged concerns regarding share price performance and committed to addressing them.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|
| Revenue | 33 | 39 | 42 | 42 |
| EBITDA | 5 | 5 | 8 | 6 |
| Net profit | 3 | 2 | 3 | 3 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
